Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse

Toxicology Letters

Volumn 167, Issue 1, 2006, Pages 8-18

  Tiboni, Gian Mario ^a   Marotta, Francesca ^a   Del Corso, Antonio ^a   Giampietro, Franca ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Itraconazole; Mouse; Teratogenic effects

Indexed keywords

ITRACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHEMICAL TERATOGENESIS; CLEFT PALATE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FETUS; GESTATIONAL AGE; LIMB DEFECT; MEDICAL EXAMINATION; MORPHOLOGY; MOUSE; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; SKELETON MALFORMATION; TOXICITY TESTING; VISCERA;

ABNORMALITIES, MULTIPLE; ANIMALS; ANTIFUNGAL AGENTS; CLEFT PALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTREMITIES; FEMALE; GESTATIONAL AGE; ITRACONAZOLE; MICE; MICE, INBRED ICR; MUSCULOSKELETAL ABNORMALITIES; PREGNANCY; TERATOGENS;

ANIMALIA;

EID: 33749987701     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.08.004     Document Type: Article

References (24)

1. Bar-Oz B., Moretti M.E., Mareels G., Van Tittelboom T., and Koren G. Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet 354 (1999) 1700-1701
2. Bar-Oz B., Moretti M.E., Bishai R., Mareels G., Van Tittelboom T., Verspeelt J., and Koren G. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am. J. Obstet. Gynecol. 183 (2000) 617-620
3. Caputo R. Itraconazole (Sporanox) in superficial and systemic fungal infections. Expert Rev. Anti. Infect. Ther. 1 (2003) 531-542
4. Inouye M. Differential staining of cartilage and bone in fetal mouse skeleton by Alcian blue and alizarin red S. Cong. Anom. 16 (1976) 171-173
5. Inman, W., Kubota, K., Pearce, G., Wilton, L., 1993. Itraconazole. Pharmacoepidemiology Drug Safety 2:423-443 (PEM report no. 7).
6. Kaufman M.H., and Bard J.B.L. The Anatomical Basis of Mouse Development (1999), Academic Press, San Diego pp. 60-76
7. Kimmel C.A., and Trammel C. A rapid procedure for routine staining of cartilage and bone in fetal and adult animals. Stain Technol. 56 (1981) 271-273
8. Kuczuk M.J., and Scott W.J. Potentiation of acetazolamide-induced ectrodactyly in SWV and C57/BL mice by cadmium sulphate. Teratology 29 (1984) 427-435
9. Lopez-Rangel E., and Van Allen M.I. Prenatal exposure to fluconazole : an identifiable dysmorphic phenotype. Birth Defects Res. Part A Clin. Mol. Teratol. 73 (2005) 919-923
10. Menegola E., Broccia M.L., Di Renzo F., Prati M., and Giavini E. In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol. In Vitro Cell Dev. Biol. Anim. 36 (2000) 88-95
11. Menegola E., Broccia M.L., Di Renzo F., and Giavini E. Antifungal triazoles induce malformations in vitro. Reprod. Toxicol. 15 (2001) 421-427
12. Menegola E., Broccia M.L., Di Renzo F., and Giavini E. Pathogenic pathways in fluconazole-induced branchial arch malformations. Birth Defects Res. Part A: Clin. Mol. Teratol. 67 (2003) 116-124
13. Menegola E., Broccia M.L., Di Renzo F., Massa V., and Giavini E. Relationship between hindbrain segmentation, neural crest cell migration and branchial arch abnormalities in rat embryos exposed to fluconazole and retinoic acid in vitro. Reprod. Toxicol. 18 (2004) 121-130
14. Moudgal V.V., and Sobel J.D. Antifungal drugs in pregnancy: a review. Expert Opin. Drug Safety 2 (2003) 475-483
15. Product Information: Sporanox, 2004. Janssen Pharmaceutica.
16. Rosa F. Azole fungicide pregnancy risks. Proceedings on the Ninth International Conference of the Organization of Teratology Information Services. Salt Lake City, Utah, May 2-4 (1996)
17. Schwartz E.L., Hallam S., Gallagher R.E., and Wiernik P.H. Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Biochem. Pharmacol. 28 (1995) 923-928
18. Tiboni G.M. Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos. Res. Commun. Chem. Pathol. Pharmacol. 79 (1993) 381-384
19. Tiboni G.M., and Giampietro F. Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence. Pediatr. Res. 58 (2005) 94-99
20. Van Cauteren H., Coussement W., Vandnerberghe J., Herin V., Vanparys P., and Marsboom R. The toxicological properties of itraconazole. In: Fromtling R.A. (Ed). Recent Trends in the Discovery, Development, and Evaluation of Antifungal Agents (1987), JR Prous, Barcelona 263-271
21. Vanden Bossche H., Ausma J., Bohets H., Vermuyten K., Willemsens G., Marichal P., Meerpoel L., Odds F., and Borgers M. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob. Agents Chemother. 48 (2004) 3272-3278
22. Vanier K.L., Mattiussi A.J., and Johnston D.L. Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia. J. Pediatr. Hematol. Oncol. 25 (2003) 403-404
23. Wilson J.C. Methods for administering agents and detecting malformations in experimental animals. In: Wilson J.G., and Warkany J. (Eds). Teratology: Principles and Techniques (1965), University of Chicago Press, Chicago 262-277
24. Woo D.C., and Hoar R.M. "Apparent hydronephrosis" as a normal aspect of renal development in late gestation of rats: the effect of methyl salicylate. Teratology 6 (1972) 191-196